A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)

SIMPLE SUMMARY: Cervical cancer is the fourth most common cancer in the world and the fourth leading cause of cancer death in women. In 2020, there were 604,000 new cases and 342,000 deaths from cervical cancer worldwide. Among these, non-squamous cell carcinoma accounts for about 20% of all cervica...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagasawa, Takayuki, Shoji, Tadahiro, Takatori, Eriko, Kaido, Yoshitaka, Kagabu, Masahiro, Shimizu, Dai, Shigeto, Tatsuhiko, Baba, Tsukasa, Sugiyama, Toru, Yokoyama, Yoshihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650927/
https://www.ncbi.nlm.nih.gov/pubmed/37958375
http://dx.doi.org/10.3390/cancers15215201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650927/
https://www.ncbi.nlm.nih.gov/pubmed/37958375
http://dx.doi.org/10.3390/cancers15215201

Ejemplares similares